Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively
Abdominal Cancer
About this trial
This is an interventional diagnostic trial for Abdominal Cancer focused on measuring major abdominal cancer
Eligibility Criteria
Inclusion Criteria:
- 60 ASA I-II cancer patients with age range (18-60) years,
- weight (50- 85) kg
Exclusion Criteria:
- with patients with known drug allergy to study drugs
- with significant cardiac, respiratory, renal or hepatic disease
- with coagulation disorders
- those with psychiatric illnesses that would interfere with perception and assessment of pain.
Sites / Locations
- South Egypt Cancer Instuite
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
TAP with bupivicaine
TAP with bupivicaine with morphine
30 patients receive ultrasound guided transversus abdominis-plane block (TAP) with local anesthetic 20 ml of bupivacaine 0.5 % diluted in 20 ml saline (total volume 40 ml) in two divided doses i.e. 20 ml is administered on each side of the abdominal wall.
30 patients receive ultrasound guided transversus abdominis-plane block (TAP) with local anesthetic 20 ml of bupivacaine 0.5% + 10 mg morphine diluted in 20 ml saline (total volume 40 ml) in two divided doses i.e. 20 ml is administered on each side of the abdominal wall.